Downregulation of NAT1 Expression is Associated with Poor Prognosis and Immune Infiltration in COAD
Houxi Xu,1,2,* Hongqun Zhang,1,3,* Songxian Sun,2 Jingyuan Zhang,2 Jiege Huo,1,3 Chunxiang Zhou2 1Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, People’s Republic of China; 2School of Traditional Chinese Me...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2024-04-01
|
| Series: | Pharmacogenomics and Personalized Medicine |
| Subjects: | |
| Online Access: | https://www.dovepress.com/downregulation-of-nat1-expression-is-associated-with-poor-prognosis-an-peer-reviewed-fulltext-article-PGPM |
| _version_ | 1797204294801293312 |
|---|---|
| author | Xu H Zhang H Sun S Zhang J Huo J Zhou C |
| author_facet | Xu H Zhang H Sun S Zhang J Huo J Zhou C |
| author_sort | Xu H |
| collection | DOAJ |
| description | Houxi Xu,1,2,* Hongqun Zhang,1,3,* Songxian Sun,2 Jingyuan Zhang,2 Jiege Huo,1,3 Chunxiang Zhou2 1Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, People’s Republic of China; 2School of Traditional Chinese Medicine, Nanjing University of Chinese Medicine, Nanjing People’s Republic of China; 3The Third School of Clinical Medicine, Nanjing University of Chinese Medicine, Nanjing, People’s Republic of China*These authors contributed equally to this workCorrespondence: Chunxiang Zhou, School of Traditional Chinese Medicine, Nanjing University of Chinese Medicine, Nanjing, 210023, People’s Republic of China, Email chunxiangzhou@njucm.edu.cn Jiege Huo, Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, 210028, People’s Republic of China, Email huojiege@jsatcm.comBackground: An increasing corpus of evidence has identified the involvement of N-acetyltransferase 1 (NAT1), a member of the NAT family, in the progression of various cancers. However, the specific function of NAT1 in colon cancer (COAD) remains elusive. This study aims to decip her the role of NAT1 in COAD and its associated mechanisms.Methods: The Tumor Immunity Evaluation Resource (TIMER), The Cancer Genome Atlas (TCGA), and the Gene Expression Omnibus (GEO) databases were employed to assess the NAT1 expression level in COAD. The differential expression between COAD and normal colon tissue was further validated using quantitative real-time reverse-transcription PCR (RT-qPCR) and Western blot (WB) analyses. Additionally, survival analysis of NAT1 in COAD was carried out using the PrognoScan database and TCGA dataset. The functions of NAT1 were explored through gene set enrichment analysis (GSEA) and immuno-infiltration analysis.Results: There was a significant reduction in NAT1 expression in COAD samples compared to normal tissue. Notably, low NAT1 expression in COAD correlated significantly with various clinical parameters such as tumor stage (T stage, N stage, M stage, pathologic stage), primary therapy outcome, carcinoembryonic antigen (CEA) level, and lymphatic invasion. The downregulation of NAT1 was also strongly linked with poor outcomes in overall survival (OS), progression-free interval (PFI), and disease-specific survival (DSS). Cox regression analysis highlighted NAT1 as an independent prognostic indicator for overall survival in COAD patients. GSEA results revealed NAT1’s involvement in multiple pathways, including the neuroactive ligand-receptor interaction, olfactory transduction, olfactory signaling, extracellular matrix receptor interaction, calcium signaling, and focal adhesion pathways. Furthermore, NAT1 expression was found to significantly correlate with infiltration levels of various immune cells.Conclusion: The findings reveal NAT1’s potential as a valuable prognostic biomarker for COAD. Moreover, its associated mechanisms offer insights that might pave the way for therapeutic interventions for COAD patients.Keywords: NAT1, COAD, prognosis, immune infiltration, RT-qPCR, western blot |
| first_indexed | 2024-04-24T08:32:57Z |
| format | Article |
| id | doaj.art-f4aba99fd0a94dc9965e61f21d900561 |
| institution | Directory Open Access Journal |
| issn | 1178-7066 |
| language | English |
| last_indexed | 2024-04-24T08:32:57Z |
| publishDate | 2024-04-01 |
| publisher | Dove Medical Press |
| record_format | Article |
| series | Pharmacogenomics and Personalized Medicine |
| spelling | doaj.art-f4aba99fd0a94dc9965e61f21d9005612024-04-16T18:59:54ZengDove Medical PressPharmacogenomics and Personalized Medicine1178-70662024-04-01Volume 1713314891994Downregulation of NAT1 Expression is Associated with Poor Prognosis and Immune Infiltration in COADXu HZhang HSun SZhang JHuo JZhou CHouxi Xu,1,2,* Hongqun Zhang,1,3,* Songxian Sun,2 Jingyuan Zhang,2 Jiege Huo,1,3 Chunxiang Zhou2 1Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, People’s Republic of China; 2School of Traditional Chinese Medicine, Nanjing University of Chinese Medicine, Nanjing People’s Republic of China; 3The Third School of Clinical Medicine, Nanjing University of Chinese Medicine, Nanjing, People’s Republic of China*These authors contributed equally to this workCorrespondence: Chunxiang Zhou, School of Traditional Chinese Medicine, Nanjing University of Chinese Medicine, Nanjing, 210023, People’s Republic of China, Email chunxiangzhou@njucm.edu.cn Jiege Huo, Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, 210028, People’s Republic of China, Email huojiege@jsatcm.comBackground: An increasing corpus of evidence has identified the involvement of N-acetyltransferase 1 (NAT1), a member of the NAT family, in the progression of various cancers. However, the specific function of NAT1 in colon cancer (COAD) remains elusive. This study aims to decip her the role of NAT1 in COAD and its associated mechanisms.Methods: The Tumor Immunity Evaluation Resource (TIMER), The Cancer Genome Atlas (TCGA), and the Gene Expression Omnibus (GEO) databases were employed to assess the NAT1 expression level in COAD. The differential expression between COAD and normal colon tissue was further validated using quantitative real-time reverse-transcription PCR (RT-qPCR) and Western blot (WB) analyses. Additionally, survival analysis of NAT1 in COAD was carried out using the PrognoScan database and TCGA dataset. The functions of NAT1 were explored through gene set enrichment analysis (GSEA) and immuno-infiltration analysis.Results: There was a significant reduction in NAT1 expression in COAD samples compared to normal tissue. Notably, low NAT1 expression in COAD correlated significantly with various clinical parameters such as tumor stage (T stage, N stage, M stage, pathologic stage), primary therapy outcome, carcinoembryonic antigen (CEA) level, and lymphatic invasion. The downregulation of NAT1 was also strongly linked with poor outcomes in overall survival (OS), progression-free interval (PFI), and disease-specific survival (DSS). Cox regression analysis highlighted NAT1 as an independent prognostic indicator for overall survival in COAD patients. GSEA results revealed NAT1’s involvement in multiple pathways, including the neuroactive ligand-receptor interaction, olfactory transduction, olfactory signaling, extracellular matrix receptor interaction, calcium signaling, and focal adhesion pathways. Furthermore, NAT1 expression was found to significantly correlate with infiltration levels of various immune cells.Conclusion: The findings reveal NAT1’s potential as a valuable prognostic biomarker for COAD. Moreover, its associated mechanisms offer insights that might pave the way for therapeutic interventions for COAD patients.Keywords: NAT1, COAD, prognosis, immune infiltration, RT-qPCR, western blothttps://www.dovepress.com/downregulation-of-nat1-expression-is-associated-with-poor-prognosis-an-peer-reviewed-fulltext-article-PGPMnat1coadprognosisimmune infiltrationrt-qpcrwestern blot |
| spellingShingle | Xu H Zhang H Sun S Zhang J Huo J Zhou C Downregulation of NAT1 Expression is Associated with Poor Prognosis and Immune Infiltration in COAD Pharmacogenomics and Personalized Medicine nat1 coad prognosis immune infiltration rt-qpcr western blot |
| title | Downregulation of NAT1 Expression is Associated with Poor Prognosis and Immune Infiltration in COAD |
| title_full | Downregulation of NAT1 Expression is Associated with Poor Prognosis and Immune Infiltration in COAD |
| title_fullStr | Downregulation of NAT1 Expression is Associated with Poor Prognosis and Immune Infiltration in COAD |
| title_full_unstemmed | Downregulation of NAT1 Expression is Associated with Poor Prognosis and Immune Infiltration in COAD |
| title_short | Downregulation of NAT1 Expression is Associated with Poor Prognosis and Immune Infiltration in COAD |
| title_sort | downregulation of nat1 expression is associated with poor prognosis and immune infiltration in coad |
| topic | nat1 coad prognosis immune infiltration rt-qpcr western blot |
| url | https://www.dovepress.com/downregulation-of-nat1-expression-is-associated-with-poor-prognosis-an-peer-reviewed-fulltext-article-PGPM |
| work_keys_str_mv | AT xuh downregulationofnat1expressionisassociatedwithpoorprognosisandimmuneinfiltrationincoad AT zhangh downregulationofnat1expressionisassociatedwithpoorprognosisandimmuneinfiltrationincoad AT suns downregulationofnat1expressionisassociatedwithpoorprognosisandimmuneinfiltrationincoad AT zhangj downregulationofnat1expressionisassociatedwithpoorprognosisandimmuneinfiltrationincoad AT huoj downregulationofnat1expressionisassociatedwithpoorprognosisandimmuneinfiltrationincoad AT zhouc downregulationofnat1expressionisassociatedwithpoorprognosisandimmuneinfiltrationincoad |